JPMorgan Chase & Co. Has $75.42 Million Stake in Novanta Inc. $NOVT

JPMorgan Chase & Co. lifted its stake in Novanta Inc. (NASDAQ:NOVT) by 4.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 753,111 shares of the technology company’s stock after acquiring an additional 30,674 shares during the period. JPMorgan Chase & Co. owned 2.10% of Novanta worth $75,424,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Arizona State Retirement System grew its holdings in Novanta by 1.6% during the third quarter. Arizona State Retirement System now owns 10,632 shares of the technology company’s stock valued at $1,065,000 after purchasing an additional 171 shares during the last quarter. M&T Bank Corp lifted its stake in shares of Novanta by 6.6% in the second quarter. M&T Bank Corp now owns 3,785 shares of the technology company’s stock worth $488,000 after buying an additional 236 shares during the last quarter. Van ECK Associates Corp lifted its stake in shares of Novanta by 17.2% in the third quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock worth $163,000 after buying an additional 239 shares during the last quarter. Amundi boosted its holdings in shares of Novanta by 1.4% during the 3rd quarter. Amundi now owns 18,287 shares of the technology company’s stock worth $1,908,000 after buying an additional 245 shares during the period. Finally, Nicolet Advisory Services LLC boosted its holdings in shares of Novanta by 7.1% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,046 shares of the technology company’s stock worth $409,000 after buying an additional 269 shares during the period. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Novanta Stock Down 1.4%

Shares of NOVT stock opened at $119.33 on Thursday. Novanta Inc. has a 12 month low of $98.27 and a 12 month high of $149.95. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. The firm has a market cap of $4.26 billion, a PE ratio of 81.73 and a beta of 1.61. The stock has a 50 day moving average of $135.24 and a 200-day moving average of $121.21.

Novanta (NASDAQ:NOVT) last announced its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.03. The business had revenue of $258.35 million for the quarter, compared to the consensus estimate of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same quarter last year, the company posted $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, equities analysts predict that Novanta Inc. will post 3.03 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Robert W. Baird set a $150.00 target price on shares of Novanta in a report on Wednesday, February 25th. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Finally, Zacks Research raised Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Novanta has a consensus rating of “Hold” and a consensus price target of $150.00.

Insider Buying and Selling at Novanta

In related news, CFO Robert Buckley sold 9,957 shares of the stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $116.77, for a total value of $1,162,678.89. Following the completion of the sale, the chief financial officer owned 96,616 shares in the company, valued at approximately $11,281,850.32. This trade represents a 9.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Matthijs Glastra sold 7,500 shares of Novanta stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total value of $1,087,800.00. Following the sale, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. This trade represents a 11.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 34,303 shares of company stock worth $4,545,416 over the last 90 days. Company insiders own 1.20% of the company’s stock.

Novanta Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.